vs
Side-by-side financial comparison of Grand Canyon Education, Inc. (LOPE) and Bio-Techne (TECH). Click either name above to swap in a different company.
Grand Canyon Education, Inc. is the larger business by last-quarter revenue ($308.1M vs $295.9M, roughly 1.0× Bio-Techne). Grand Canyon Education, Inc. runs the higher net margin — 28.1% vs 12.8%, a 15.3% gap on every dollar of revenue. On growth, Grand Canyon Education, Inc. posted the faster year-over-year revenue change (5.3% vs -6.4%). Over the past eight quarters, Grand Canyon Education, Inc.'s revenue compounded faster (5.9% CAGR vs 4.2%).
Grand Canyon Education, Inc. (GCE) is an American for-profit corporation that provides services to universities, specializing in program development, online education, and operational support. Formerly affiliated with Grand Canyon University (GCU), a Christian university in Arizona, GCE became a separate publicly traded company in 2008.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
LOPE vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $308.1M | $295.9M |
| Net Profit | $86.7M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 35.1% | 18.4% |
| Net Margin | 28.1% | 12.8% |
| Revenue YoY | 5.3% | -6.4% |
| Net Profit YoY | 5.9% | 68.3% |
| EPS (diluted) | $3.13 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $308.1M | $295.9M | ||
| Q3 25 | $261.1M | — | ||
| Q2 25 | $247.5M | $317.0M | ||
| Q1 25 | $289.3M | $316.2M | ||
| Q4 24 | $292.6M | $297.0M | ||
| Q3 24 | $238.3M | $289.5M | ||
| Q2 24 | $227.5M | $306.1M | ||
| Q1 24 | $274.7M | $303.4M |
| Q4 25 | $86.7M | $38.0M | ||
| Q3 25 | $16.3M | — | ||
| Q2 25 | $41.5M | $-17.7M | ||
| Q1 25 | $71.6M | $22.6M | ||
| Q4 24 | $81.9M | $34.9M | ||
| Q3 24 | $41.5M | $33.6M | ||
| Q2 24 | $34.9M | $40.6M | ||
| Q1 24 | $68.0M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 35.1% | 18.4% | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 20.9% | -7.5% | ||
| Q1 25 | 30.4% | 12.2% | ||
| Q4 24 | 34.2% | 16.0% | ||
| Q3 24 | 20.2% | 13.8% | ||
| Q2 24 | 18.8% | 15.0% | ||
| Q1 24 | 30.8% | 22.1% |
| Q4 25 | 28.1% | 12.8% | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 16.8% | -5.6% | ||
| Q1 25 | 24.8% | 7.1% | ||
| Q4 24 | 28.0% | 11.7% | ||
| Q3 24 | 17.4% | 11.6% | ||
| Q2 24 | 15.3% | 13.3% | ||
| Q1 24 | 24.8% | 16.2% |
| Q4 25 | $3.13 | $0.24 | ||
| Q3 25 | $0.58 | — | ||
| Q2 25 | $1.48 | $-0.11 | ||
| Q1 25 | $2.52 | $0.14 | ||
| Q4 24 | $2.83 | $0.22 | ||
| Q3 24 | $1.42 | $0.21 | ||
| Q2 24 | $1.19 | $0.26 | ||
| Q1 24 | $2.29 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.8M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $746.9M | $2.0B |
| Total Assets | $992.3M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.8M | $172.9M | ||
| Q3 25 | $97.3M | — | ||
| Q2 25 | $192.3M | $162.2M | ||
| Q1 25 | $144.5M | $140.7M | ||
| Q4 24 | $324.6M | $177.5M | ||
| Q3 24 | $263.6M | $187.5M | ||
| Q2 24 | $241.3M | $152.9M | ||
| Q1 24 | $196.2M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $746.9M | $2.0B | ||
| Q3 25 | $758.0M | — | ||
| Q2 25 | $778.0M | $1.9B | ||
| Q1 25 | $780.7M | $2.0B | ||
| Q4 24 | $783.9M | $2.1B | ||
| Q3 24 | $764.1M | $2.1B | ||
| Q2 24 | $759.2M | $2.1B | ||
| Q1 24 | $759.4M | $2.0B |
| Q4 25 | $992.3M | $2.5B | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $1.0B | $2.6B | ||
| Q4 24 | $1.0B | $2.7B | ||
| Q3 24 | $992.9M | $2.7B | ||
| Q2 24 | $992.7M | $2.7B | ||
| Q1 24 | $1.0B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.5M | — |
| Free Cash FlowOCF − Capex | $122.9M | — |
| FCF MarginFCF / Revenue | 39.9% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 1.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $238.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.5M | — | ||
| Q3 25 | $-48.6M | — | ||
| Q2 25 | $124.0M | $98.2M | ||
| Q1 25 | $67.6M | $41.1M | ||
| Q4 24 | $135.8M | $84.3M | ||
| Q3 24 | $-29.4M | $63.9M | ||
| Q2 24 | $98.6M | $75.5M | ||
| Q1 24 | $85.0M | $81.0M |
| Q4 25 | $122.9M | — | ||
| Q3 25 | $-58.3M | — | ||
| Q2 25 | $115.4M | $93.3M | ||
| Q1 25 | $58.7M | $31.0M | ||
| Q4 24 | $126.1M | $77.5M | ||
| Q3 24 | $-39.0M | $54.7M | ||
| Q2 24 | $89.6M | $57.5M | ||
| Q1 24 | $76.0M | $64.5M |
| Q4 25 | 39.9% | — | ||
| Q3 25 | -22.3% | — | ||
| Q2 25 | 46.6% | 29.4% | ||
| Q1 25 | 20.3% | 9.8% | ||
| Q4 24 | 43.1% | 26.1% | ||
| Q3 24 | -16.3% | 18.9% | ||
| Q2 24 | 39.4% | 18.8% | ||
| Q1 24 | 27.7% | 21.3% |
| Q4 25 | 2.5% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.5% | 1.5% | ||
| Q1 25 | 3.1% | 3.2% | ||
| Q4 24 | 3.3% | 2.3% | ||
| Q3 24 | 4.0% | 3.2% | ||
| Q2 24 | 3.9% | 5.9% | ||
| Q1 24 | 3.3% | 5.4% |
| Q4 25 | 1.50× | — | ||
| Q3 25 | -2.99× | — | ||
| Q2 25 | 2.98× | — | ||
| Q1 25 | 0.94× | 1.82× | ||
| Q4 24 | 1.66× | 2.42× | ||
| Q3 24 | -0.71× | 1.90× | ||
| Q2 24 | 2.83× | 1.86× | ||
| Q1 24 | 1.25× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOPE
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
